Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if the Government will produce a strategy to provide NHS support for problem gamblers who wish to receive anonymous treatment.
Answered by Baroness Blackwood of North Oxford
There are no plans to do so. There are a range of services available to problem gamblers, details of which can be found on the NHS Choices website at:
www.nhs.uk/Livewell/addiction/Pages/gamblingaddiction.aspx
Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 25 October 2016 to Question HL2227, how his Department monitors clinical commissioning groups on waiting times for cataracts surgery.
Answered by Philip Dunne
The Department uses the National Health Service performance data published on a monthly basis by NHS England in respect of waiting times for consultant-led referral to treatment waiting times to monitor compliance with waiting times targets for treatment. Referral to treatment data are collected by 18 specialties and are not condition or procedure specific. Cataract surgery is included in the ophthalmology specialty. This information is published at both provider and commissioner level and is available at the following link:
https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/
Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how his Department monitors compliance with government targets on waiting times for treatment.
Answered by Philip Dunne
The Department uses the National Health Service performance data published on a monthly basis by NHS England to monitor compliance with waiting times targets for treatment. This information is available at the following link:
https://www.england.nhs.uk/statistics/statistical-work-areas/
Maintaining waiting time performance is a key objective in the Government’s Mandate to NHS England. Both NHS England and NHS Improvement are providing support and challenge to NHS commissioners and providers to reduce waiting times for hospital treatment.
Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what statistics (a) his Department, (b) NHS trusts and (c) clinical commissioning groups (CCGs) hold on referrals to treatment by (i) NHS trusts and (ii) CCGs.
Answered by Philip Dunne
Official statistics are published by NHS England on a monthly basis in respect of waiting times for consultant-led referral to treatment waiting times. These statistics provide the length of time from referral through to elective treatment for 18 high volume specialties. This information is published at both provider and commissioner level. Further information can be found at this link:
https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/
Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the level of cervical screening uptake is in Wolverhampton Clinical Commissioning Group; what steps his Department is taking to increase cervical screening uptake among women in Wolverhampton; and if he will make a statement.
Answered by David Mowat
Cervical screening data is provided at local authority level and is published by Public Health England (PHE).
The percentage of women in the resident population of Wolverhampton who are eligible for cervical screening who were screened adequately within the previous 3.5 years or 5.5 years according to age (3.5 years for women aged 25-49 and 5.5 years for women aged 50-64) on 31 March is 68.1%.
Cervical screening is commissioned by NHS England and is based upon a national service specification developed by PHE. NHS England closely monitors the coverage rates for cervical screening in all age groups and is committed to improving coverage and reducing variation between all age groups. In Wolverhampton, NHS England is working with local sexual health services to improve access for women who wish to access the cervical screening programme outside of general practice. PHE and NHS England are also working with general practices with lowest levels of uptake to understand barriers and mechanisms for improvement.
The human papillomavirus (HPV) adolescent vaccination programme for girls is well established in the United Kingdom and is expected to have a significant impact on reducing cervical cancer. Since the start of the programme in 2008, more than 8.5 million doses of the HPV vaccine have been given in the UK, with close to 90% of eligible teenagers vaccinated.
Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how long patients in Wolverhampton waited on average to start treatment following diagnosis for (a) lung cancer, (b) breast cancer, (c) cervical cancer, (d) ovarian cancer, (e) prostate cancer, (f) testicular cancer, (g) pancreatic cancer, (h) head and neck cancers, (i) leukaemia, (j) bowel cancer, (k) kidney cancer, (l) colon cancer, (m) GIST cancers, (n) stomach cancer, (o) liver cancer, (p) melanoma, (q) non-Hodgkin Lymphoma and (r) myeloma in each year since 1997; what the average (i) one, (ii) five and (iii) 10 year age-standardised net survival rate for each of those cancers was in each year since 1997; and what proportion of people with each of those cancers was diagnosed at stage (A) 1, (B) 2, (C) 3 and (D) 4 in each year since 1997.
Answered by David Mowat
Data are not available in the format requested.
Data is published by NHS England on the proportion of patients who received treatment within 62 days of referral by provider for six tumour types: breast, lower gastrointestinal, lung, other, skin, and urological (excluding testicular). These data can be found at:
https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/monthly-prov-cwt/
Staging data is published by the National Cancer Registration and Analysis Service for 13 tumour types: bladder, breast, oesophagus, stomach, colorectal, pancreas, kidney, lung, melanoma, Non-Hodgkin lymphoma, ovarian, uterine, and prostate. These data can be found at:
http://www.ncin.org.uk/publications/survival_by_stage
Data on one and five year survival rates for 16 tumour types are provided in Table 1. These data are not published at provider level.
Asked by: Emma Reynolds (Labour - Wycombe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what costs have been (a) incurred and (b) committed for future periods for the development and management of the sustainability and transformation plan process for Wolverhampton Clinical Commissioning Group.
Answered by David Mowat
Wolverhampton Clinical Commissioning Group (CCG) is part of the Black Country Sustainability and Transformation Plan (STP). The majority of work to date on the STP has been managed through existing staff resources of partner organisations, with a small element of external support being funded from management resources.
Partner organisations are contributing to support multiple programmes and work streams set out in the plan, and staff are working on the STP in addition to their other management roles. As a result, the total cost of developing the STP to date is not held centrally. Plans are currently being drafted outlining the resources and financial commitment needed by the CCG for the development and management of the Black Country STP for the forthcoming financial year.